Over 200 Leading Companies Enhance Trial Efficiency with Veeva CTMS
In a significant advancement for clinical trial management, Veeva Systems has announced that more than 200 companies have adopted its Clinical Trial Management System (CTMS), including an impressive 17 of the top 20 biopharmaceutical companies. This surge in adoption highlights a growing recognition of the need for efficient trial management solutions in the complex landscape of clinical research.
With the ever-increasing complexity of studies and the massive volumes of data involved, these companies are leveraging Veeva CTMS to centralize their data and documents. This system facilitates streamlined processes and enhances collaboration among various stakeholders. Bonne Adams, Vice President of Operations at Inhibrx, expressed the importance of Veeva CTMS as the central hub for their trials, describing how it allows for seamless flow of study metrics and documents across their ecosystem. Adams emphasized that using clinical applications on a connected platform not only saves time for their lean team but also significantly improves interactions with Clinical Research Organization (CRO) partners.
As clinical teams navigate both insourced and outsourced trials, Veeva CTMS offers tools to proactively manage studies, allowing for rapid identification and resolution of issues. This flexible and scalable system enables companies to expedite trial execution while ensuring compliance with international regulations, such as ICH E6(R2) and (R3).
Veeva Systems is constantly innovating to help biopharmaceutical companies adapt to evolving trial models and regulatory requirements. Some recent advancements in Veeva CTMS include automated daily data transfers from CROs to sponsors, providing greater visibility and oversight issue tracking for quicker resolutions, and enhanced capabilities to manage complex, insourced, and outsourced trials effectively.
Henry Galio, Vice President of Veeva CTMS Strategy, stated that modern clinical trial management systems must scale easily and support diverse operational models. To accommodate these needs, Veeva is committed to delivering new capabilities through three product releases annually. This strategy ensures that the system continuously evolves, allowing the life sciences industry to collaborate more effectively and accelerate trial execution.
As Veeva CTMS gains popularity, it becomes clear that companies are simplifying their trial operations and maintaining compliance no matter their operational model. Positioned as a critical component of the Veeva Clinical Platform, Veeva CTMS stands out as one of the most comprehensive and efficient solutions for modern trials.
To explore more on Veeva CTMS and participate in the continued evolution of clinical trial management, industry professionals have the opportunity to join the Veeva RD and Quality Summit in Madrid on June 4-5, 2025. Here, they can learn from experts in the field and discuss the future of clinical trials. For further details, professionals can register through Veeva’s platform and stay updated on advancements that could reshape their trial management approaches.
For more information about Veeva CTMS, potential users can visit veeva.com/eu/CTMS or connect with Veeva on LinkedIn to stay updated on the latest developments and innovations.
About Veeva Systems: Veeva Systems is recognized as a global frontrunner in cloud software tailored for the life sciences sector. The company is dedicated to innovation and product quality, serving over 1,000 clients ranging from the biggest biopharmaceutical entities to innovative biotech startups. As a Public Benefit Corporation, Veeva emphasizes a commitment to balancing the interests of all stakeholders, including customers, employees, shareholders, and the broader life sciences industry. More information can be found at veeva.com/eu.
With the ever-increasing complexity of studies and the massive volumes of data involved, these companies are leveraging Veeva CTMS to centralize their data and documents. This system facilitates streamlined processes and enhances collaboration among various stakeholders. Bonne Adams, Vice President of Operations at Inhibrx, expressed the importance of Veeva CTMS as the central hub for their trials, describing how it allows for seamless flow of study metrics and documents across their ecosystem. Adams emphasized that using clinical applications on a connected platform not only saves time for their lean team but also significantly improves interactions with Clinical Research Organization (CRO) partners.
As clinical teams navigate both insourced and outsourced trials, Veeva CTMS offers tools to proactively manage studies, allowing for rapid identification and resolution of issues. This flexible and scalable system enables companies to expedite trial execution while ensuring compliance with international regulations, such as ICH E6(R2) and (R3).
Veeva Systems is constantly innovating to help biopharmaceutical companies adapt to evolving trial models and regulatory requirements. Some recent advancements in Veeva CTMS include automated daily data transfers from CROs to sponsors, providing greater visibility and oversight issue tracking for quicker resolutions, and enhanced capabilities to manage complex, insourced, and outsourced trials effectively.
Henry Galio, Vice President of Veeva CTMS Strategy, stated that modern clinical trial management systems must scale easily and support diverse operational models. To accommodate these needs, Veeva is committed to delivering new capabilities through three product releases annually. This strategy ensures that the system continuously evolves, allowing the life sciences industry to collaborate more effectively and accelerate trial execution.
As Veeva CTMS gains popularity, it becomes clear that companies are simplifying their trial operations and maintaining compliance no matter their operational model. Positioned as a critical component of the Veeva Clinical Platform, Veeva CTMS stands out as one of the most comprehensive and efficient solutions for modern trials.
To explore more on Veeva CTMS and participate in the continued evolution of clinical trial management, industry professionals have the opportunity to join the Veeva RD and Quality Summit in Madrid on June 4-5, 2025. Here, they can learn from experts in the field and discuss the future of clinical trials. For further details, professionals can register through Veeva’s platform and stay updated on advancements that could reshape their trial management approaches.
For more information about Veeva CTMS, potential users can visit veeva.com/eu/CTMS or connect with Veeva on LinkedIn to stay updated on the latest developments and innovations.
About Veeva Systems: Veeva Systems is recognized as a global frontrunner in cloud software tailored for the life sciences sector. The company is dedicated to innovation and product quality, serving over 1,000 clients ranging from the biggest biopharmaceutical entities to innovative biotech startups. As a Public Benefit Corporation, Veeva emphasizes a commitment to balancing the interests of all stakeholders, including customers, employees, shareholders, and the broader life sciences industry. More information can be found at veeva.com/eu.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.